Urologic Oncology: Seminars and Original Investigations : Impact Factor & More
eISSN: 1873-2496pISSN: 1078-1439
Share this on:
Key Metrics
CiteScore 
4.7
H-Index
79
Impact Factor
< 5
SJR
Q1Urology
SNIP
1.01
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Urologic Oncology: Seminars and Original Investigations
Urologic Oncology: Seminars and Original Investigations Journal Specifications
| Overview | |
| Publisher | ELSEVIER SCIENCE INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2003 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Urologic Oncology: Seminars and Original Investigations ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Urologic Oncology: Seminars and Original Investigations
Featured SUO Fellow: Alon Y. Lazarovich, MD, MBA.
- 1 Dec 2025
- Urologic oncology
Cover 2 - Masthead
- 1 Dec 2025
- Urologic Oncology: Seminars and Original Investigations
Targeted hotspot profiling reveals a functionally relevant mutation in bladder cancer.
- 1 Dec 2025
- Urologic oncology
Editorial Board
- 1 Dec 2025
- Urologic Oncology: Seminars and Original Investigations
Table of Contents
- 1 Dec 2025
- Urologic Oncology: Seminars and Original Investigations
Neoadjuvant pembrolizumab and tyrosine kinase inhibitor to facilitate imperative partial nephrectomy for renal cell carcinoma.
- 21 Nov 2025
- Urologic oncology
Featured SUO Fellow: Alon Y. Lazarovich, MD, MBA.
- 1 Dec 2025
- Urologic oncology
Cover 2 - Masthead
- 1 Dec 2025
- Urologic Oncology: Seminars and Original Investigations
Targeted hotspot profiling reveals a functionally relevant mutation in bladder cancer.
- 1 Dec 2025
- Urologic oncology
Editorial Board
- 1 Dec 2025
- Urologic Oncology: Seminars and Original Investigations
Table of Contents
- 1 Dec 2025
- Urologic Oncology: Seminars and Original Investigations
Neoadjuvant pembrolizumab and tyrosine kinase inhibitor to facilitate imperative partial nephrectomy for renal cell carcinoma.
- 21 Nov 2025
- Urologic oncology
FAQs on Urologic Oncology: Seminars and Original Investigations
How long has Urologic Oncology: Seminars and Original Investigations been actively publishing? 
What is the publishing frequency of Urologic Oncology: Seminars and Original Investigations?
How many articles did Urologic Oncology: Seminars and Original Investigations publish last year?
What is the eISSN & pISSN for Urologic Oncology: Seminars and Original Investigations?
What is Citescore for Urologic Oncology: Seminars and Original Investigations?
What is the H Index for Urologic Oncology: Seminars and Original Investigations ?
What is SNIP score for Urologic Oncology: Seminars and Original Investigations?
What is the SJR for Urologic Oncology: Seminars and Original Investigations?
Who is the publisher of Urologic Oncology: Seminars and Original Investigations?
